World Health Organization (WHO)

Last Updated 8 December 2021.

8 Vaccines Approved for Use by WHO

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 79 countries

  33 trials in 8 countries

  Approval Source: who.int

  RNA

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 112 countries

  46 trials in 21 countries

  Approval Source: who.int

  RNA

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 85 countries

  16 trials in 18 countries

  Approval Source: who.int

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 127 countries

  52 trials in 23 countries

  Approval Source: who.int

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield (Oxford/AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 47 countries

  2 trials in 1 country

  Approval Source: who.int

  Non Replicating Viral Vector

• Bharat Biotech
  Covaxin

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 12 countries

  7 trials in 1 country

  Approval Source: extranet.who.int

  Inactivated

• Sinopharm (Beijing)
  BBIBP-CorV (Vero Cells)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 72 countries

  19 trials in 10 countries

  Approval Source: who.int

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 47 countries

  26 trials in 8 countries

  Approval Source: who.int

  Inactivated